Journal Home
Search for

Articles in Press

Return to articles in press list

Adverse Effects of Long-Term Proton Pump Inhibitor Use: A Review for the Otolaryngologist

D. Brandon Chapman, Catherine J. ReesCorresponding Author Informationemail address, Dylan Lippert, Robert T. Sataloff, S. Carter Wright Jr.

published online 08 February 2010.
Corrected Proof

Objective

Proton pump inhibitors (PPIs) are the mainstay of current medical management for laryngopharyngeal reflux, and treatment often involves long-term use of this class of medications. The long-term adverse effects of PPI use have not been studied extensively, but several analyses have demonstrated epidemiological links between PPI use and adverse outcomes. These include altered mineral and vitamin absorption, orthopedic injury, acute coronary syndromes (ACS), and infectious risks.

Study Design

A PubMed search was performed for subject headings, including PPIs and adverse outcomes. Relevant studies were included in this review. Studies were compiled, reviewed, and compared in a narrative form.

Results

Several epidemiological links between PPI use and metabolic, infectious, cardiac, and orthopedic adverse outcomes were found. No definite causal effects were identified.

Conclusion

Given these epidemiological patterns, we recommend that the clinician be aware of these possible unintended consequences. In addition, we recommend consideration of dual-energy X-ray absorptiometry (DEXA) bone density scans in at-risk patients who have not been previously tested. We recommend consideration of vitamin B12 and iron levels in selected patients who are at high risk. We also recommend close communication with our cardiology colleagues, as we attempt to ascertain the relationship between clopidogrel and PPI use. We recommend caution in the use of omeprazole in patients undergoing active treatment for ACS. Finally, we recommend consideration of Helicobacter pylori or serum gastrin level testing in patients with known risk factors for gastric carcinoma.

∗Winston Salem, North Carolina and †Philadelphia, Pennsylvania

 Department of Otolaryngology, Center for Voice and Swallowing Disorders, Wake Forest University Health Sciences, Winston Salem, North Carolina

 Department of Otolaryngology—Head and Neck Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania

Corresponding Author InformationAddress correspondence and reprint requests to Catherine J. Rees, Department of Otolaryngology, Center for Voice and Swallowing Disorders, Wake Forest University Health Sciences, Medical Center Boulevard, Winston Salem, NC 27157.

PII: S0892-1997(09)00204-5

doi:10.1016/j.jvoice.2009.10.015